XML 109 R87.htm IDEA: XBRL DOCUMENT v3.24.0.1
Schedule I - Condensed Statements of Cash Flows (Detail) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash Flows From Operating Activities:      
Net income $ 234,196 $ 291,190 $ 256,513
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Equity in net income of subsidiary (234,196) (291,190) (256,513)
Net cash provided by (used in) operating activities 504,916 564,588 503,012
Cash Flows From Investing Activities:      
Net cash used in investing activities (305,607) (200,705) (128,854)
Cash Flows From Financing Activities:      
Exercise of stock options 2,940 3,028 5,907
Net cash (used in) provided by financing activities (34,707) (726,049) (364,897)
Change in Cash and Cash Equivalents, including Restricted Cash 164,602 (362,166) 9,261
Cash and Cash Equivalents, including Restricted Cash—Beginning of year 82,320 444,486 435,225
Cash and Cash Equivalents, including Restricted Cash—End of year 246,922 82,320 444,486
Parent Company [Member]      
Cash Flows From Operating Activities:      
Net income 234,196 291,190 256,513
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Equity in net income of subsidiary (234,196) (291,190) (256,513)
Cash Flows From Investing Activities:      
Capital contributed to subsidiary from exercises of stock options (2,884) (3,431) (5,955)
Net cash used in investing activities (2,884) (3,431) (5,955)
Cash Flows From Financing Activities:      
Exercise of stock options 2,940 3,028 5,907
Net cash (used in) provided by financing activities 2,940 3,028 5,907
Change in Cash and Cash Equivalents, including Restricted Cash 56 (403) (48)
Cash and Cash Equivalents, including Restricted Cash—Beginning of year 4 407 455
Cash and Cash Equivalents, including Restricted Cash—End of year 60 4 407
Supplemental Disclosures of Noncash Financing Activities      
Dividends from subsidiary- return of capital, for purchase of treasury stock 17,861 693,623 215,749
Parent Company [Member] | Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]      
Cash Flows From Operating Activities:      
Net income 234,196 291,190 256,513
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Equity in net income of subsidiary $ (234,196) $ (291,190) $ (256,513)